These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15796195)

  • 1. Osteoclasts resorb protein-free mineral (Osteologic discs) efficiently in the absence of osteopontin.
    Contractor T; Babiarz B; Kowalski AJ; Rittling SR; Sørensen ES; Denhardt DT
    In Vivo; 2005; 19(2):335-41. PubMed ID: 15796195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulsed electromagnetic fields stimulation affects osteoclast formation by modulation of osteoprotegerin, RANK ligand and macrophage colony-stimulating factor.
    Chang K; Chang WH; Huang S; Huang S; Shih C
    J Orthop Res; 2005 Nov; 23(6):1308-14. PubMed ID: 15913941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
    Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
    Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage colony stimulating factor increases bone resorption in dispersed osteoclast cultures by increasing osteoclast size.
    Lees RL; Heersche JN
    J Bone Miner Res; 1999 Jun; 14(6):937-45. PubMed ID: 10352102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation.
    de Vries TJ; Schoenmaker T; Beertsen W; van der Neut R; Everts V
    J Cell Biochem; 2005 Apr; 94(5):954-66. PubMed ID: 15578568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral down-regulation of osteopontin inhibits human osteoclast differentiation in vitro.
    Aitken CJ; Hodge JM; Nicholson GC
    J Cell Biochem; 2004 Nov; 93(5):896-903. PubMed ID: 15389974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts.
    Suzuki K; Zhu B; Rittling SR; Denhardt DT; Goldberg HA; McCulloch CA; Sodek J
    J Bone Miner Res; 2002 Aug; 17(8):1486-97. PubMed ID: 12162503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts.
    Tanaka H; Tanabe N; Shoji M; Suzuki N; Katono T; Sato S; Motohashi M; Maeno M
    Life Sci; 2006 Mar; 78(15):1733-40. PubMed ID: 16266722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
    Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
    J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells.
    Islam S; Hassan F; Tumurkhuu G; Dagvadorj J; Koide N; Naiki Y; Mori I; Yoshida T; Yokochi T
    Biochem Biophys Res Commun; 2007 Aug; 360(2):346-51. PubMed ID: 17597583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone.
    Asou Y; Rittling SR; Yoshitake H; Tsuji K; Shinomiya K; Nifuji A; Denhardt DT; Noda M
    Endocrinology; 2001 Mar; 142(3):1325-32. PubMed ID: 11181551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts.
    Miyamoto A; Kunisada T; Hemmi H; Yamane T; Yasuda H; Miyake K; Yamazaki H; Hayashi SI
    Biochem Biophys Res Commun; 1998 Jan; 242(3):703-9. PubMed ID: 9464281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone.
    Dodds RA; Connor JR; James IE; Rykaczewski EL; Appelbaum E; Dul E; Gowen M
    J Bone Miner Res; 1995 Nov; 10(11):1666-80. PubMed ID: 8592943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin antisense deoxyoligonucleotides inhibit bone resorption by mouse osteoclasts in vitro.
    Tani-Ishii N; Tsunoda A; Umemoto T
    J Periodontal Res; 1997 Aug; 32(6):480-6. PubMed ID: 9379315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin deficiency suppresses high phosphate load-induced bone loss via specific modulation of osteoclasts.
    Koyama Y; Rittling SR; Tsuji K; Hino K; Salincarnboriboon R; Yano T; Taketani Y; Nifuji A; Denhardt DT; Noda M
    Endocrinology; 2006 Jun; 147(6):3040-9. PubMed ID: 16513836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
    Adamopoulos IE; Wordsworth PB; Edwards JR; Ferguson DJ; Athanasou NA
    Hum Pathol; 2006 Sep; 37(9):1176-85. PubMed ID: 16938523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin inhibits osteoclastogenesis while enhancing osteoclast activity via nitric oxide and interleukin-1β-mediated signaling pathways.
    Gramoun A; Azizi N; Sodek J; Heersche JN; Nakchbandi I; Manolson MF
    J Cell Biochem; 2010 Nov; 111(4):1020-34. PubMed ID: 20672308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins modulate the levels of osteoprotegerin/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures.
    Kaji H; Kanatani M; Sugimoto T; Chihara K
    Horm Metab Res; 2005 Oct; 37(10):589-92. PubMed ID: 16278780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.